Slideshows

Take a look back at our most popular podcast episodes and videos for 2022.

Take a look back at our most popular conference coverage for 2022.

Take a look back at our most popular biosimilars coverage for 2022.

This holiday season, share these tips to and avoid getting—and spreading—COVID-19.

Take a look back at our most popular Total Pharmacy business strategy coverage for 2022.

Take a look back at our most popular pediatric coverage for 2022.

Take a look back at our most popular respiratory coverage for 2022.

A look at what’s to come in the December issue of Drug Topics®

A look at what’s to come in the November issue of Drug Topics®

A selection of the latest COVID-19 vaccine research out of IDWeek 2022.

A look at what’s to come in the October issue of Drug Topics®

Take in these top tips for pharmacy front-end management.

New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.

Both drugs address an unmet need for patients with hemophilia A or B.

The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.

A look at what’s to come in the May issue of Drug Topics®

A look at what’s to come in the April issue of Drug Topics®

The drugs treat a range of conditions, including migraine, Alzhiemer disease, and actinic keratosis.

A look at what’s to come in the March issue of Drug Topics®

The states pharmacists should avoid.

A look at incidence rates, survival rates, and more.

Where pharmacists should be looking to live.

Noteworthy diabetes management products and updates making waves this year.

Which states are the most likely to vaccinate-and which ones are most likely to skip?

A look at some of the exciting drugs that could be approved in the coming months.